By Mayo Clinic Staff
A positron emission tomography (PET) scan is an imaging test that helps reveal how your tissues and organs are functioning. A PET scan uses a radioactive drug (tracer) to show this activity.
The tracer may be injected, swallowed or inhaled, depending on which organ or tissue is being studied by the PET scan. The tracer collects in areas of your body that have higher levels of chemical activity, which often correspond to areas of disease. On a PET scan, these areas show up as bright spots.
A PET scan is useful in revealing or evaluating several conditions, including some cancers, heart disease and brain disorders.
A PET scan is an effective way to examine the chemical activity in parts of your body. It may help identify a variety of conditions, including some cancers, heart disease and brain disorders. The pictures from a PET scan provide information different from that uncovered by other types of scans, such as computerized tomography (CT) or magnetic resonance imaging (MRI). A PET scan or a combined CT-PET scan enables your doctor to better diagnose your condition.
Cancer cells show up as bright spots on PET scans because they have a higher metabolic rate than do normal cells. PET scans may be useful in:
- Detecting cancer
- Revealing whether your cancer has spread
- Checking whether a cancer treatment is working
- Finding a cancer recurrence
PET scans must be interpreted carefully because noncancerous conditions can look like cancer, and many types of cancer do not appear on PET scans. The types of cancer most likely to show up on PET scans include:
- Head and neck
PET scans can reveal areas of decreased blood flow in the heart. This information can help you and your doctor decide, for example, whether you might benefit from a procedure to open clogged heart arteries (angioplasty) or coronary artery bypass surgery.
PET scans can be used to evaluate certain brain disorders, such as:
- Alzheimer's disease
For your PET scan, a radioactive drug (tracer) will be put into your body. The amount of radiation you're exposed to is small, and the risk of negative effects from it is low. But the tracer might:
- Cause a major allergic reaction, in rare instances
- Expose your unborn baby to radiation if you are pregnant
- Expose your child to radiation if you are breast-feeding
Talk with your doctor about the benefits and risks of a PET scan.
Tell your doctor:
- If you've ever had a bad allergic reaction
- If you've been sick recently or you have another medical condition, such as diabetes
- If you're taking any medications, vitamins or herbal supplements
- If you're pregnant or think you might be pregnant
- If you're breast-feeding
- If you're afraid of enclosed spaces (claustrophobic)
Your doctor will give you detailed instructions on how to prepare for your scan. A general rule is to avoid strenuous exercise for a couple of days before the study and to stop eating a few hours before the scan.
The PET scanner is a large machine that looks a little like a giant doughnut standing upright, similar to a computerized tomography (CT) machine. You'll need about two hours for the procedure, which may be done on an outpatient basis (no overnight hospital stay). When you arrive for your scan, you may be asked to:
- Change into a hospital gown
- Empty your bladder
Then you will be given a radioactive drug (tracer). You may receive the drug by injection or be asked to inhale or swallow it, depending on the type of tracer being used. If the drug is injected, you may briefly feel a cold sensation moving up your arm. You'll need to wait 30 to 60 minutes for the tracer to be absorbed by your body.
During the PET scan
When you are ready, you'll lie on a narrow, padded table that slides into the scanner. During the scan you'll need to lie very still so that the images aren't blurred. It takes about 30 minutes to complete the test. The machine makes buzzing and clicking sounds.
The test is painless. If you're afraid of enclosed spaces, you may feel some anxiety while in the scanner. Be sure to tell the nurse or technologist about any discomfort. He or she may give you a drug to help you relax.
In some cases you may have a CT and PET scan in the same machine during the same appointment. The CT scan will be done first and take about 10 minutes.
After the PET scan
After the test you can carry on with your day as usual, unless your doctor tells you otherwise. You'll need to drink plenty of fluids to help flush the tracer from your body.
Pictures from a PET scan display bright spots where the radioactive tracer collected. These spots reveal higher levels of chemical activity and details about how your tissues and organs are functioning. A doctor specially trained to interpret scan images (radiologist) will report the findings to your doctor.
The radiologist may also compare your PET images with images from other tests you've undergone recently, such as computerized tomography (CT) or magnetic resonance imaging (MRI). Or the pictures may be combined to provide more detail about your condition.
May 06, 2014
- Javery O, et al. FDG PET or PET/CT in patients with pancreatic cancer: When does it add to diagnostic CT or MRI? Clinical Imaging 37;2013:295.
- Murphy JG, et al., eds. Mayo Clinic Cardiology: Concise Textbook. 4th ed. New York, N.Y.: Oxford University Press; 2013:130.
- Ziessman HA, et al. Nuclear Medicine: The Requisites. 4th ed. Philadelphia, Pa.: Saunders Elsevier; 2014.
- Positron emission tomography — Computed tomography (PET/CT). Radiological Society of North America. http://www.radiologyinfo.org/en/info.cfm?pg=PET. Accessed Dec. 11, 2013.
- About nuclear medicine and molecular imaging. Society of Nuclear Medicine and Molecular Imaging. http://www.snmmi.org/AboutSNMMI/Content.aspx?ItemNumber=6433&navItemNumber=756. Accessed Dec. 11, 2013.
- About PET scans. American College of Radiology Imaging Network. http://www.acrin.org/patients/aboutimagingexamsandagents/aboutpetscans.aspx. Accessed Dec. 11, 2013.
- Riggin EA. Decision Support System. Mayo Clinic, Rochester, Minn. Nov. 20, 2013.
- AskMayoExpert. Lung cancer surveillance in at-risk patients. Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2013.
- Mitchell CR, et al. Operational characteristics of (11)c-choline positron emission tomography/computerized tomography for prostate cancer with biochemical recurrence after initial treatment. Journal of Urology. 2013;189:1308.
- ACR appropriateness criteria pretreatment staging of colorectal cancer. Rockville, Md.: Agency for Healthcare Research and Quality. http://www.guideline.gov/content.aspx?id=35139. Accessed Dec. 19, 2013.
- FDA approves production of imaging agent that helps detect prostate cancer. U.S. Food and Drug Administration. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm319201.htm. Accessed Dec. 18, 2013.